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Abstract
Background: A wider biological role of 1alpha,25-Dihydroxyvitamin D3 (1,25(OH)2D3), the
active metabolite of vitamin D3, in tissues not primarily related to mineral metabolism was
suggested. Recently, we evidenced the ultrastructural localization the 1,25(OH)2D3 receptor in
the human sperm. However, the 1,25(OH)2D3 action in human male reproduction has not yet
been clarified.
Methods and Results: By RT-PCR, Western blot and Immunofluorescence techniques, we
demonstrated that human sperm expresses the 1,25(OH)2D3 receptor (VDR). Besides,
25(OH)D3-1 alpha-hydroxylase, evidenced by Western blot analysis, indicated that in sperm
1,25(OH)2D3 is locally produced, highlighting the potential for autocrine-paracrine responses.
1,25(OH)2D3 through VDR, increased intracellular Ca2+ levels, motility and acrosin activity
revealing an unexpected significance of this hormone in the acquisition of fertilizing ability. In sperm,
1,25(OH)2D3 through VDR, reduces triglycerides content concomitantly to the increase of lipase
activity. Rapid responses stimulated by 1,25(OH)2D3 have been observed on Akt, MAPK and GSK3
implying that this secosteroid is involved in different sperm signalling pathways.
Conclusion: Our data extended the role of 1,25(OH)2D3 beyond its conventional physiological
actions, paving the way for novel therapeutic opportunities in the treatment of the male
reproduction disorders.
Background
1 alpha,25-dihydroxyvitamin D3  (1,25(OH)2D3), the
active metabolite of vitamin D3, is formed after hydroxy-
lation by the rate-limiting enzyme 25(OH)D3-1 alpha-
hydroxylase (1 alpha-hydroxylase), abundantly expressed
in the renal proximal tubule [1]. 1,25(OH)2D3 is a secos-
teroid whose actions are mediated by binding to its cog-
nate nuclear receptor, the vitamin D receptor (VDR), a
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member of the nuclear hormone receptor superfamily [2].
The VDR exerts 1,25(OH)2D3-dependent responses in
the nucleus as a ligand-activated transcription factor [3].
In addition to these relatively slow genomic effects,
1,25(OH)2D3 generates rapid responses including Ca2+
uptake from intestine [4,5], augmentation of insulin
secretion from pancreatic β-cells [6,7], growth and differ-
entiation of vascular smooth muscle cells [8] and kerati-
nocytes [9]. The initial signal is amplified by production
of second messengers including inositol triphosphate and
diacylglycerol in the plasma membrane by phospholipase
C, phosphoinositol 3-kinase [8], production of cAMP
[10], and activation of the MAPK pathway [11]. Vitamin
D regulates Ca2+ homeostasis and VDR expression is not
limited to organs involved in Ca2+ regulation, suggesting
that 1,25(OH)2D3 may perform different functions in a
tissue specific manner.
Previous studies suggested that 1,25(OH)2D3 has some
role in reproductive functions. The VDR is widely distrib-
uted in male and female reproductive tissues [12], imply-
ing a 1,25(OH)2D3 action in these organs. In humans,
VDR was observed in the testis, in the prostate and in sper-
matozoa [12-14]. Particularly, our group by immunogold
analysis showed that VDR was localised uniformly in the
sperm nucleus, although some particles also decorated the
neck of the sperm [15]. Vitamin D deficiency and vitamin
D receptor null mutant mice showed gonadal insufficien-
cies [16,17]. Uterine hypoplasia and impaired folliculo-
genesis were observed in the female, decreased sperm
count and motility with histological abnormality of the
testis were observed in the male. However, the role of
1,25(OH)2D3 in the testis is unclear. Different nuclear
receptors [18,19] were found to be present in human ejac-
ulated spermatozoa, regulating cellular processes through
their nongenomic mechanisms. Sperm is a useful cellular
type to study these effects since they are transcriptional
inactive cells [20]. Indeed, sperm functionalities need to
be rapidly activated to accommodate dynamic changes in
the surrounding milieu. The significance of
1,25(OH)2D3/VDR in male fertility is not yet been fully
investigated. The current finding evaluated the potential
role of 1,25(OH)2D3/VDR system in human sperm phys-
iology by studying its effect on Ca2+ levels, motility, acro-
sin activity, glucose and lipid metabolism. Furthermore,
rapid 1,25(OH)2D3 responses were evaluated on differ-




PMN Cell Isolation Medium was from BIOSPA (Milan,
Italy). Total RNA Isolation System kit, enzymes, buffers,
nucleotides 100 bp ladder used for RT-PCR were pur-
chased from Promega (Milan, Italy). Moloney Murine
Leukemia Virus (M-MLV) was from Gibco - Life Technol-
ogies Italia (Milan, Italy). Oligonucleotide primers were
made by Invitrogen (Milan, Italy). BSA protein standard,
Laemmli sample buffer, prestained molecular weight
markers, Percoll (colloidal PVP coated silica for cell sepa-
ration), Sodium bicarbonate, Sodium lactate, Sodium
pyruvate, Dimethyl Sulfoxide (DMSO), Earle's balanced
salt solution (uncapacitating medium), 1alpha,25-Dihy-
droxyvitamin D3 (1,25(OH)2D3) and all other chemicals
were purchased from Sigma Chemical (Milan, Italy). Acr-
ylamide bisacrylamide was from Labtek Eurobio (Milan,
Italy). Triton X-100, fetal calf serum (FCS) was from Invit-
rogen (Milan, Italy), Eosin Y was from Farmitalia Carlo
Erba (Milan, Italy). ECL Plus Western blotting detection
system, Hybond™ECL™, Hepes Sodium Salt were pur-
chased from Amersham Pharmacia Biotech (Buckingham-
shire, UK). Triglycerides assay kit, lipase activity kit,
calcium (Ca2+) assay kit, Glucose-6-phosphate dehydro-
genase (G6PDH) activity assay kit were from Inter-Medi-
cal (Biogemina Italia Srl, Catania, Italy). Goat polyclonal
actin Ab (1-19), monoclonal mouse anti-VDR (D-6) Ab,
rabbit anti-p-Akt1/Akt2/Akt3 S473 Ab, peroxidase-cou-
pled anti-rabbit and anti-goat IgG secondary Abs, anti-
rabbit IgG FITC conjugated, Protein A/G-agarose plus
were from Santa Cruz Biotechnology (Heidelberg, Ger-
many). Rabbit anti-p-extracellular signal-regulated kinase
(ERK 1/2) and anti-p-GSK3 Abs were from Cell Signalling
(Milan, Italy). Mouse anti-1α-hydroxylase Ab was from
the Binding Site Ltd (Birmingham, UK).
Semen collection, sperm processing and experimental 
treatments
Human semen was collected, according to the World
Health Organization (WHO) recommended procedure by
masturbation from healthy volunteer donors of proven
fertility undergoing semen analysis in our laboratory.
Spermatozoa preparations were performed as previously
described [21]. Briefly, sperm samples with normal
parameters of semen volume, sperm count, motility, vital-
ity and morphology, according to the WHO Laboratory
Manual [22], were included in this study. Further, the
results of routine semen analysis on subjects included in
the study are reported in the Table 1. Each sperm sample
was obtained by pooling the ejaculates of three different
normozoospermic healthy donors. After liquefaction,
normal semen samples were pooled and subjected to cen-
Table 1: Mean of the semen parameters from all the sample used 
(n. 21)
Semen Parameters Mean ± SD
Volume (mL) 3.54 ± 0.3
Sperm concentration (106/mL) 75.2 ± 2.4
Motility (%) 47.2 ± 1.82
Morfology (%) 45 ± 1.2Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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trifugation (600 g) on a discontinuous Percoll density gra-
dient (95:40% v:v) [23]. The 95% Percoll fraction was
examined using an optical microscope equipped with a
×100 oil objective to ensure that a pure sample of sperm
was obtained. An independent observer, who examined
several fields for each slide, inspected the cells. Percoll-
purified sperm were washed with unsupplemented Earle's
balanced salt solution medium (uncapacitating medium)
and were incubated in the same medium for 30 min at
37°C and 5% CO2, without (control) or with increasing
concentrations of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM
and 10 nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3. When the cells were treated with the anti-
VDR Ab, a pre-treatment of 15 min was performed. Other
samples were incubated in capacitating medium (Earle's
balanced salt solution medium supplemented with 266
mg/100 ml CaCl2, 600 mg/100 ml BSA, 3 mg/100 ml
sodium pyruvate, 360 μl/100 ml sodium lactate, and 200
mg/100 ml sodium bicarbonate).
After the incubation time, the samples were centrifuged
and the pellet containing sperm was lysed to perform RT-
PCR, western blots, triglycerides assay, Ca2+ assay, acyl-
CoA dehydrogenase assay, glucose6-phosphate dehydro-
genase (G6PDH) activity, lipase activity. Prior the centrif-
ugation several aliquots were used to perform sperm
motility, viability and acrosin activity. To evaluate the
expression of the VDR in samples with severe oligoasten-
ozoospermia (subjects with a sperm count less than 10 ×
106/ml and motility less than 20%) the western blotting
analysis was performed by pooling three different samples
with purified sperms. The study was approved by the local
medical-ethical committees and all participants gave their
informed consent.
RNA isolation, Reverse Transcriptase-Polymerase Chain 
Reaction (RT-PCR)
Total RNA was isolated from human ejaculated spermato-
zoa purified as abovementioned. Before RT-PCR, RNA
was incubated with ribonuclease-free deoxyribonuclease
(Dnase) I in single-strength reaction buffer at 37°C for 15
min. This was followed by heat inactivation of Dnase I at
65°C for 10 min. Two micrograms of Dnase-treated RNA
samples were reverse transcribed by 200 IU M-MLV
reverse transcriptase in a reaction volume of 20 μl (0.4 μg
oligo-dT, 0.5 mM deoxy-NTP and 24 IU Rnasin) for 30
min at 37°C, followed by heat denaturation for 5 min at
95°C. PCR amplification of complementary DNA
(cDNA) was performed with 2 U of Taq DNA polymerase,
50 pmol primer pair in 10 mM Tris-HCL (pH 9.0) con-
taining 0.1% Triton X-100, 50 mM KCl, 1.5 mM MgCl2
and 0.25 mM each dNTP. Potential contamination by leu-
cocytes and germ cells in our sperm cells preparations was
assessed by amplifying CD45 and c-kit transcripts respec-
tively. The applied PCR primers and the expected lengths
of the resulting PCR products are shown in Table 2. For all
PCR amplifications (40 cycles), negative (reverse tran-
scription-PCR performed without M-MLV reverse tran-
scriptase) and positive controls were included: MCF7
breast cancer cells for VDR [24], human germ cells for c-
Kit and human leucocytes for CD45. Cycling conditions
were: 95°C/1 min, 55°C/1 min, 72°C/2 min for VDR;
95°C/1 min, 52°C/1 min, 72°C/2 min for c-kit; 95°C/1
min, 55°C/1 min, 72°C/2 min for CD45. The PCR-ampli-
fied products were subjected to electrophoresis in 2% aga-
rose gels stained with ethidium bromide and visualised
under UV transillumination.
Gel extraction and DNA sequence analysis
The VDR RT-PCR product was extracted from the agarose
gel by using a gel band purification kit, the purified DNA
was subcloned into PCR 2.1 vector and then sequenced by
MWG AG Biotech (Ebersberg, Germany).
Evaluation of sperm motility
Sperm motility was assessed by means of light microscopy
examining an aliquot of each sperm sample in absence
(NC, control) or in the presence of increasing concentra-
tions of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM and 10
nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3 and incubated for 30 min under uncapaci-
tating conditions (experimental). Sperm motility was
expressed as percentage of total motile sperm.
Western blot analysis of sperm proteins
Percoll-purified sperm, washed twice with Earle's bal-
anced salt solution, were incubated without (NC) or with
the treatments indicated in the legend of each figure, and
then centrifuged for 5 min at 5000 × g. Besides, some sam-
ples were washed and incubated in capacitating medium.
Table 2: Oligonucleotide sequences used for RT-PCR
Gene Sequence (5' - 3') Size of PCR product (bp)
VDR 5' - CTCCCCCTGCCAGTGCCTTACCTC - 3'
5' - CCCCGCTCTCCCTTCCCACACT - 3'
299
KIT 5' - AGTACATGGACATGAAACCTGG - 3'
5' - GATTCTGCTCAGACATCGTCG - 3'
780
PTPRC 5' - CAATAGCTACTACTCCATCTAAGCCA - 3'
5' - ATGTCTTATCAGGAGCAGTACATG - 3'
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The pellet was resuspended in lysis buffer as previously
described [23]. Equal amounts of protein (80 μg) were
boiled for 5 min, separated by 10% polyacrylamide gel
electrophoresis, transferred to nitrocellulose sheets and
probed with an appropriate dilution of the indicated Abs.
The bound of the secondary antibody was revealed with
the ECL Plus Western blotting detection system according
to the manufacturer's instructions. As internal control, all
membranes were subsequently stripped (glycine 0.2 M,
pH 2.6 for 30 min at room temperature) of the first Ab
and reprobed with anti-β actin.
Immunofluorescence assay
Sperm cells, recovered from Percoll gradient, were rinsed
three times with 0.5 mM Tris-HCl buffer, pH 7.5 and fixed
with absolute methanol for 7 min at -20°C. VDR staining
was carried out, after blocking with normal horse serum
(10%), using a monoclonal anti-human VDR as primary
Ab (1 μg/ml) and an anti-mouse IgG FITC conjugated (4
μg/ml) as secondary Ab. Sperm cells incubated without
the primary Ab or with normal mouse serum instead of
the primary Ab were utilized as the negative controls. The
slides were examined under a fluorescence microscope
(Olympus BX41, Milan Italy), and a minimum of 200
spermatozoa per slide were scored.
Evaluation of Ca2+ in sperm lysate
Ca2+  was determined according to the manufacturer
instructions [25] and as previously described [26]. At a
neutral pH, the Ca2+ forms with arsenazo III a complex,
the colour intensity of which is directly proportional to
the concentration of Ca2+ in the sample. Percoll-purified
sperm, washed twice with Earle's balanced salt solution,
were incubated in the absence (NC, control) or in the
presence of increasing concentrations of 1,25(OH)2D3
(0.01 nM, 0.1 nM, 1 nM and 10 nM) or with anti-VDR Ab
combined with 0.1 nM 1,25(OH)2D3 for 30 min in a
Ca2+ serum free medium (uncapacitating medium). 1 ml
of the reagent, 4-morpholinoethanesulfonic acid (MES) at
pH 6.5 (100 mM) and Arsenazo III (200 μM), was added
to the sperm lysate, mixed and incubated for 5 minutes at
+15-25°C. The optical density was measured with the
spectrophotometer at 600 nm. Ca2+ content Ca2+ standard
used was 2.5 mM (100 mg/l). Inter- and intra-assay varia-
tion were 0.24% and 0.37%. Ca2+ results are presented as
μM per 10 × 106 number of spermatozoa.
Acrosin activity assay
Acrosin activity was assessed by the method of Kennedy et
al.  [27] and as previously described [28]. Sperm were
washed in Earle's medium and centrifuged at 800 g for 20
min, then were resuspended (final concentration of 10 ×
106 sperm/ml) in different tubes containing no treatment
(NC, control) or sperm were treated with increasing con-
centrations of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM and
10 nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3 and incubated for 30 min under uncapaci-
tating conditions (experimental). 1 ml of substrate-deter-
gent mixture (23 mmol/l BAPNA in DMSO and 0.01%
Triton X-100 in 0.055 mol/l NaCl, 0.055 mol/l HEPES at
pH 8.0 respectively) was added and incubated for 3 hours
at room temperature. Aliquots (20 μl) were removed at 0
and 3 hours and the percentages of viable cells were deter-
mined. After incubation, 0.5 mol/l benzamidine was
added (0.1 ml) to each of the tubes and then centrifuged
at 1000 g for 30 min. The supernatants were collected and
the acrosin activity measured with the spectrophotometer
at 410 nm. In this assay, the total acrosin activity is
defined as the amount of the active (non-zymogen) acro-
sin associated with sperm plus the amount of active acro-
sin that is obtained by proacrosin activable. The acrosin
activity was expressed as μIU/106 sperms. Quantification
of acrosin activity was performed as previously described
[28].
Triglycerides Assay
Triglycerides were measured in duplicate by a GPO-POD
enzymatic colorimetric method according to manufac-
turer's instructions in sperm lysates and as previously
described [29]. Sperm samples, washed twice with unca-
pacitating medium, were incubated in the same medium
(control) or in capacitating medium for 30 min at 37°C
and 5% CO2. Other samples were incubated in the pres-
ence of increasing concentrations of 1,25(OH)2D3 (0.01
nM, 0.1 nM, 1 nM and 10 nM) or with anti-VDR Ab com-
bined with 0.1 nM 1,25(OH)2D3, for 30 min under unca-
pacitating conditions.
At the end of the sperm incubation 50 μg of sperm extracts
were added to the 1 ml of buffer reaction and incubated
for 10 min at room temperature. Then the triglycerides
content was measured with the spectrophotometer at 505
nm. Data are presented as μg/106 sperms.
Assay of acyl-CoA dehydrogenase activity
Assay of acyl-CoA dehydrogenase was performed on
sperm, using a modification of the method described by
Lehman et al. [30]. Sperm samples, washed twice with
uncapacitating medium, were incubated in the same
medium (control) for 30 min at 37°C and 5% CO2. Other
samples were incubated in the presence of increasing con-
centrations of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM and
10 nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3, for 30 min under uncapacitating condi-
tions. In brief, after lysis, 70 μg of sperm protein was
added to buffer containing 20 mM Mops, 0.5 mM EDTA,
and 100 μM FAD+ at pH 7.2. Reduction of FAD+ to FADH
was read at 340 nm upon addition of octanoyl-CoA (100
μM) every 20 seconds for 1.5 min. Data are expressed as
nmol/min/mg protein. The enzymatic activity was deter-Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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mined with three control media: one without octanoyl-
CoA as substrate, one without the coenzyme (FAD+), and
the third without either substrate or coenzyme (data not
shown).
Lipase activity assay
Lipase activity was evaluated, by the method of
Panteghini [31] based on the use of 1,2-o-dilauryl-rac-
glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR)
as substrate. Sperm samples, washed twice with uncapac-
itating medium, were incubated in the same medium
(control) for 30 min at 37°C and 5% CO2. Other samples
were incubated in the presence of increasing concentra-
tions of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM and 10
nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3, for 30 min under uncapacitating condi-
tions. 50 μg of sperm extracts were loaded into individual
cuvettes containing buffer for determination with the
spectrophotometer. DGGR is cleaved by lipase, resulting
in an unstable dicarbonic acid ester which is spontane-
ously hydrolysed to yield glutaric acid and methylresoru-
fin, a bluish-purple chromophore with peak absorption at
580 nm. The absorbance of samples was read every 20 sec-
onds for 1.5 min. The rate of methylresorufin formation is
directly proportional to the lipase activity in the sample.
Analysis of total imprecision gave a coefficient of varia-
tion of between 0.01% and 0.03%. The estimated refer-
ence interval was 6-38 U/L (μmol/min/mg protein). The
enzymatic activity was determined with three control
media: one without the substrate, one without the co-
enzyme (colipase) and the third without either substrate
or co-enzyme (data not shown).
G6PDH activity
The conversion of NADP+  to NADPH, catalyzed by
G6PDH, was measured by the increase of absorbance at
340 nm. Sperm samples, washed twice with uncapacitat-
ing medium, were incubated in the same medium (con-
trol) for 30 min at 37°C and 5% CO2. Other samples were
incubated in the presence of sperm treated with increasing
concentrations of 1,25(OH)2D3 (0.01 nM, 0.1 nM, 1 nM
and 10 nM) or with anti-VDR Ab combined with 0.1 nM
1,25(OH)2D3 and incubated for 30 min under uncapaci-
tating conditions. After incubation, 50 μg of sperm
extracts were loaded into individual cuvettes containing
buffer (100 mM triethanolamine, 100 mM MgCl2, 10 mg/
ml glucose-6-phosphate, 10 mg/ml NADP+, pH 7.6) for
determination with the spectrophotometer. The absorb-
ance of samples was read at 340 nm every 20 seconds for
1.5 min. Data are expressed in nmol/min/106 sperms. The
enzymatic activity was determined with three control
media: one without glucose-6-phosphate as substrate, one
without the coenzyme (NADP+), and the third without
either substrate or coenzyme (data not shown).
Statistical analysis
The experiments for RT-PCR and immunofluorescence
assays were repeated on at least three independent occa-
sions, whereas Western blot analysis was performed in at
least seven independent experiments. The data obtained
from triglycerides Assay, G6PDH activity, acyl-CoA dehy-
drogenase activity, Ca2+ assay and lipase activity (seven
replicate experiments using duplicate determinations),
motility (five replicate experiments using duplicate deter-
minations), acrosin activity (seven replicate experiments
using duplicate determinations) were presented as the
mean ± SD. The differences in mean values were calcu-
lated using analysis of variance (ANOVA) with a signifi-
cance level of P ≤ 0.05.
Results
VDR expression in human sperm
To determine whether mRNA for VDR is present in
human ejaculated spermatozoa, RNA isolated from per-
coll-separated sperm of normal men was subjected to
reverse PCR. The primer sequences were based on the
human VDR gene sequence and the RT-PCR amplification
revealed the expected PCR product size of 299 bp of the
coding region of the human VDR cDNA (Fig 1A). This
product was sequenced and found to be corresponding to
the classical human VDR (data not shown). No detectable
levels of mRNA coding either CD45, a specific marker of
human leucocytes, or c-kit, a specific marker of human
germ cells, were found in the same semen samples (Fig
1A), ruling out any potential contamination. In addition,
the RT-PCR products were not a result of any DNA con-
tamination as the RNA samples were subjected to DNAse
treatment before RT-PCR.
The presence of VDR protein in human ejaculated sperm
was investigated by Western blot (Fig 1B) using a mouse
monoclonal Ab raised against amino acids 344-424 of
VDR (D-6) of human origin, purchased by Santa Cruz
Biotechnology. Two immunoreactive bands, correspond-
ing to the molecular mass values of 52 and 57 kDa were
observed. Two different cellular types were used as posi-
tive controls: MCF7, breast cancer cells, that showed two
bands, one of 48 kDa as previously reported [32] and
another one at 52 kDa; LNCap, prostate cancer cells, that
showed one band at 52/54 [33]. Interestingly, as shown in
the panel C, it appears that pathologic samples exhibit a
reduced expression of VDR, particularly of the 52 kDa
band.
A local Vitamin D Metabolism occurs in human sperm
The 1 alpha-hydroxylase is a member of the cytochrome
P450 superfamily and it is a key enzyme of vitamin D
metabolism. In order to investigate whether in sperm a
local Vitamin D metabolism exists, we did perform a west-Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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ern blot by using an anti-1alpha-hydroxylase Ab. As
shown in Fig. 1D one band, corresponding to the molec-
ular mass value of 56 kDa was observed like in somatic
cells [34].
VDR localization in human sperm
Using a immunofluorescence technique and the same
anti-VDR Ab used for western blot, we obtained a positive
signal for VDR in human spermatozoa. The immunoreac-
tivity was predominantly compartmentalized in the
sperm head (Fig 2A) and a weak staining was also
observed in the midpiece. No fluorescent signal was
obtained when primary Ab was omitted (Fig 2B) or when
the normal mouse IgG was used instead of the primary Ab
(Fig. 2C), thus further confirming the specificity of the
antibody binding.
1,25(OH)2D3 regulates intracellular Ca2+ content in 
human sperm
1,25(OH)2D3 plays not only a pivotal role in systemic
Ca2+ homeostasis but also in the intracellular Ca2+ home-
ostasis of various tissues [35]. Recently it was demon-
strated that internal sperm Ca2+ stores provide sufficient
Ca2+ for the induction of hyperactived motility [36]. It is
important to point out that serum human 1,25(OH)2D3
levels between 37.5 and 150 pM (15 - 60 pg/ml) can be
regarded as physiological concentrations [37] whereas 1
nM and 10 nM are supraphysiological levels. Our results
showed that 1,25(OH)2D3 from 0.01 nM to 1 nM is able
to increase intracellular Ca2+, however not in a dose
dependent manner and 10 nM 1,25(OH)2D3 didn't show
a significant increase (Fig. 3); the combination of anti-
VDR Ab with 0.1 nM 1,25(OH)2D3 reduced this action.
These data may address an important role of
1,25(OH)2D3/VDR in sperm Ca2+ regulation.
1,25(OH)2D3 influences sperm motility and acrosin 
activity
As it was never investigated, a functional assessment of the
sperm under 1,25(OH)2D3 was performed to evaluate
motility and acrosin activity. Sperm motility was
enhanced upon 0.01 nM and 0.1 nM 1,25(OH)2D3,
while the combination of the anti-VDR Ab with 0.1 nM
1,25(OH)2D3 reduced this effect. 1 nM and 10 nM
1,25(OH)2D3 appear to be ineffective (Fig. 4A). Besides,
we evaluated whether 1,25(OH)2D3 is able to influence
the sperm extratesticular maturation by evidencing its
potential action on acrosin activity.
A significant a dose-dependent effect from 0.01, 0.1 and 1
nM 1,25(OH)2D3 on increased acrosin activity was
observed (Fig. 4B). The 10 nM 1,25(OH)2D3 didn't show
a further increase with respect to the 1 nM concentration.
The process was significantly reduced by using the anti-
VDR expression in human ejaculated spermatozoa Figure 1
VDR expression in human ejaculated spermatozoa. 
A: Reverse transcription-PCR analysis of human VDR, CD45 
and c-Kit genes in percolled human spermatozoa (S1 and S2), 
negative control (no M-MLV reverse transcriptase added) (-), 
positive controls (MCF7 breast cancer cells for VDR, human 
germ cells for c-Kit and human leucocytes for CD45) (+), 
marker (lane M). Arrows indicated the expected size of the 
PCR products. B: Western blot of VDR protein in human 
sperm, expression in two samples of ejaculated spermatozoa 
from normal men (S1, S2). MCF-7 and LNCaP extracts were 
used as positive controls. C: VDR expression in severe oli-
goastenozoospermic patients. NC = Normal uncapacitated 
sample; P1, P2 = pathologic samples. D: Western blot of 
1alpha--hydroxylase protein in human sperm, expression in 
two samples of ejaculated spermatozoa from normal men 
(S1, S2). MCF-7 extracts was used as positive control (+). 
The experiments were repeated at least four times for RT-
PCR, seven times for Western blot and the autoradiographs 
of the figure show the results of one representative experi-
ment.Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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VDR Ab combined with 0.1 nM 1,25(OH)2D3 suggesting
an involvement of the receptor in the acrosome reaction.
1,25(OH)2D3 affects human sperm metabolism
During sperm extratesticular maturation an overall
increase in sperm metabolism occurs. However, the mech-
anisms that govern this event are still poorly understood.
In order to give further insight on this aspect of sperm
physiology we studied a potential role of VDR in lipid and
glucose sperm metabolism, by evaluating the intracellular
levels of triglycerides, lipase activity, acyl-CoA dehydroge-
nase activity and G6PDH activity. 1,25(OH)2D3 stimula-
tion induced a significant dose-dependent decrease from
0.01, 0.1 and 1 nM 1,25(OH)2D3, addressing a lipolytic
effect, while the 10 nM 1,25(OH)2D3 was ineffective. The
anti-VDR Ab reversed the 0.1 nM 1,25(OH)2D3 effect
addressing a VDR-dependent event (Table 3). The lipase
activity was enhanced from 0.01 nM to 1 nM
1,25(OH)2D3, however not in a dose dependent manner.
10 nM 1,25(OH)2D3 appears to be ineffective and the
combination of anti-VDR Ab with 0.1 nM 1,25(OH)2D3
indicates a VDR-mediated effect. No differences between
treated and control samples were observed both in the
Immunofluorescence localization of VDR in human ejaculated  spermatozoa Figure 2
Immunofluorescence localization of VDR in human 
ejaculated spermatozoa. A: VDR Immunolocalization; B: 
Sperm cells incubated without the primary Ab were utilized 
as negative control. C: Sperm cells incubated replacing the 
anti-VDR Ab by normal rabbit serum were utilized as nega-
tive control. The pictures shown are representative exam-
ples of experiments that were performed at least three times 
with reproducible results.
1,25(OH)2D3 increases intracellular Ca2+ Figure 3
1,25(OH)2D3 increases intracellular Ca2+. Percoll-puri-
fied sperm washed spermatozoa were incubated in the 
unsupplemented Earle's medium for 30 min at 37°C and 5% 
CO2, in the absence (NC) or in the presence of increasing 
1,25(OH)2D3 concentrations (0.01 nM, 0.1 nM, 1 nM and 10 
nM) or with 0.1 nM 1,25(OH)2D3 combined with anti-VDR 
Ab (AbVDR). Other samples were incubated in capacitating 
medium (Cap). Intracellular calcium was measured as 
reported in Materials and Methods. The calcium assay pre-
sented are representative examples of experiments that 
were performed at least seven times with repetitive results. 
Columns represent mean ± S.D. *P < 0.05 versus control, **P 
< 0.02, ***P < 0.01 versus control.Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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1,25(OH)2D3 effects on motility and acrosin activity are VDR-mediated Figure 4
1,25(OH)2D3 effects on motility and acrosin activity are VDR-mediated. Percoll-purified sperm washed spermato-
zoa were incubated in the unsupplemented Earle's medium for 30 min at 37°C and 5% CO2, in the absence (NC) or in the 
presence of increasing 1,25(OH)2D3 concentrations (0.01 nM, 0.1 nM, 1 nM and 10 nM) or with 0.1 nM 1,25(OH)2D3 com-
bined with anti-VDR Ab (AbVDR). Other samples were incubated in capacitating medium (Cap). Sperm motility and acrosin 
activity were assessed as reported in Materials and methods. The sperm motility presented are representative examples of 
experiments that were performed at least five times with repetitive results while acrosin activity were performed at least 
seven times with repetitive results. Columns are mean ± S.D. Data are expressed as % for motility and as μIU acrosin/106 
sperms for acrosin activity. *P < 0.05 versus control; ** P < 0.02, ***P < 0.01 versus control.Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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acyl-CoA dehydrogenase and in the G6PDH activities
upon increasing 1,25(OH)2D3.
1,25(OH)2D3 activates ERK1/2, Akt and GSK3 in human 
sperm
The mechanisms involved in the control of sperm func-
tions are not yet well known; strong evidences indicate
that they are associated with or controlled by different sig-
nal transduction elements. Therefore, we aimed to inves-
tigate 1,25(OH)2D3 rapid action on different kinases
identified in sperm, such as the ERK1/2, AKT and GSK3,
by evaluating their phosphorylations. Increasing doses of
the secosteroid from 0.01 nM to 0.1 nM resulted in signif-
icant induction of the ERK1/2, AKT and GSK3 phosphor-
ylations (Fig. 5A), while the 1 nM and 10 nM
concentrations appear to be ineffective. Particularly, the 1
nM 1,25(OH)2D3 increased only the AKT phosphoryla-
tion. Anti-VDR Ab abolished 0.1 nM 1,25(OH)2D3-
induced effect, demonstrating that in sperm
1,25(OH)2D3 is able to activate different signalling path-
ways through VDR and therefore it might contribute to
different sperm biological functions.
To investigate if the phosphorylations of the abovemen-
tioned kinases, induced by 0.1 nM 1,25(OH)2D3 may
represent an early event, we performed a time course study
(0, 5, 10, 30 and 60 min). This experiment revealed that
the ERK1/2, AKT and GSK3 phosphorylations occurred
rapidly as they were observed from 5 min, increased at 10
min and were sustained until 30 min, then dropped sig-
nificantly after 1 hour (Fig. 5B).
Discussion
1,25(OH)2D3 is a key regulator of Ca2+  homeostasis
through binding to specific receptor-VDR [38]. The arche-
typal target organs of this hormone include bone, intes-
tines and kidney. Indeed, diverse array of tissues that do
not participate in mineral and bone metabolism possess
specific VDR and sequentially respond to 1,25(OH)2D3,
including testis [13]. However, the role of 1,25(OH)2D3
in the physiology of genitourinary organs, is still princi-
pally unknown. In our study we aimed to investigate
1,25(OH)2D3 functional role in sperm physiology and
the molecular mechanisms through which this secoster-
oid may affect human male reproduction, discovering
new 1,25(OH)2D3 actions.
First, we identified VDR in sperm at different levels:
mRNA presence, protein expression and its localization.
Previous reports demonstrating the size of the VDR by gel
electrophoresis, showed that it varies depending on the
species studied with a molecular weight ranging from 50
to 60 kDa. Human testis showed a protein of 57 and
another one of 52 kDa molecular weight compared with
57 and 37 kDa in the rat testis [39]. Human prostate evi-
denced protein of 52 kDa compared to rat ventral (57 and
37 kDa) and dorsal prostate (52 and 26 kDa). Our data on
VDR isoforms are super imposable to that found in
human testis. Recently, in human sperm, VDR was
reported at 50 kDa size [14], and this discrepancy with our
data may be due to different methodological approaches
and/or to the antibody used. It appears that a lower
amount of VDR is expressed in pathologic samples that
have severe oligoastenozoospermia. The VDR localization
by immunofluorescence assay confirmed the data
observed in our previous study, showing by immunogold
analysis that VDR was localised in the sperm nucleus,
although some particles also decorated the neck [15]. In
somatic cells, the receptor-hormone complex becomes
localized to the nucleus and then interacts with the
1,25(OH)2D3-responsive element, modifying transcrip-
tion of the target genes. In addition to their classic
genomic action, nuclear receptors regulate cellular proc-
esses through a non-genomic mechanism [40]. It is gener-
ally accepted that the sperm nucleus is transcriptional
inactive due to the highly condensed architecture of its
chromatin. In this study, we investigated the rapid effects
of the VDR as we have also observed previously for other
nuclear receptors in human sperm [18,29,41]. Indeed,
this mode of action seems to be particularly appropriate











NC 0,08 ± 0.0013 0,5 ± 0.02 0,004 ± 0.0001 0,005 ± 0.0001
1,25(OH)2D3 0.01 nM 0,05 ± 0.001* 1,3 ± 0.04* 0,0039 ± 0.0001 0,0048 ± 0.0002
1,25(OH)2D3 0.1 nM 0,025 ± 0.0029** 1,8 ± 0.03** 0,0041 ± 0.0002 0,0047 ± 0.0002
1,25(OH)2D3 1 nM 0,015 ± 0.0032** 0,8 ± 0.032* 0,0040 ± 0.0003 0,0051 ± 0.00018
1,25(OH)2D3 10 nM 0,07 ± 0.002 0,6 ± 0.031 0,0038 ± 0.0001 0,0046 ± 0.0001
Ab VDR + 0.1 nM 
1,25(OH)2D3
0,077 ± 0.0019 0,4 ± 0.041 0,0038 ± 0.0002 0,0049 ± 0.0002
CAP 0.06 ± 0.002 2,2 ± 0,045** 0,01 ± 0,0005** 0.01 ± 0,0003*
Data are presented as mean ± S.D. of seven independent experiments performed in duplicate.
*P < 0.05 versus control; ** P < 0.01 versus control (NC). CAP = capacitated sperms.Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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in the male gamete because sperm functions need to be
activated rapidly to accommodate dynamic changes in the
surrounding milieu. Importantly, our study also evi-
denced that 1,25(OH)2D3 is a locally produced hormone
as the male gamete expresses the 1α, hydroxylase. The
presence of this protein in sperm and the VDR raises the
possibility of an autocrine short loop.
Sperm physiology depends on nongenomic signals
amongst which Ca2+ have an important role [42,43],
however, its regulation is poorly understood. Autono-
mous 1,25(OH)2D3 production together the presence of
VDR led us to hypothesize an autocrine regulation of
Ca2+ in sperm, on the basis of this classical 1,25(OH)2D3
role at systemic level. There is considerable evidences that
Ca2+ stores exist in mammalian spermatozoa and recently
it was demonstrated that they play an important role in
triggering hyperactivated motility. In fact, internal Ca2+
stores could provide sufficient Ca2+ for the induction of
hyperactivation, afterwards the Ca2+ influx is required to
1,25(OH)2D3 induces pERK1/2, AKT and GSK3 phosphorylations in human sperm through VDR Figure 5
1,25(OH)2D3 induces pERK1/2, AKT and GSK3 phosphorylations in human sperm through VDR. A: Percoll-puri-
fied sperm washed spermatozoa were incubated in the unsupplemented Earle's medium for 30 min at 37°C and 5% CO2, in the 
absence (NC) or in the presence of increasing 1,25(OH)2D3 concentrations (0.01 nM, 0.1 nM, 1 nM and 10 nM) or with 0.1 
nM 1,25(OH)2D3 combined with anti-VDR Ab (AbVDR). Other samples were incubated in capacitating medium (Cap). B: 
Time course study (0, 5, 10, 30 and 60 min) of ERK1/2, AKT and GSK3 phosphorylations treated with 0.1 nM 1,25(OH)2D3. 
Actin was used as loading control. On the side are reported the densitometric evaluations normalised against actin levels. The 
autoradiographs presented are representative examples of experiments that were performed at least seven times with repeti-
tive results. *P < 0.05 versus control, **P < 0.01, ***P < 0.002 versus control.Reproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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maintain intracellular Ca2+ levels sufficient to maximize
and sustain this process that led to the acrosome reaction
[36]. From our data it emerges that 1,25(OH)2D3,
through VDR, is able to increase intracellular Ca2+ levels,
addressing a role for the receptor in the induction of
hyperactivated motility, that in turn triggers or contributes
to the sperm changes associated to capacitation and acro-
some reaction. The mechanisms controlling the interac-
tion between energy balance and reproduction are the
subject of intensive investigations. Capacitated sperm dis-
play an increased metabolism and overall energy expend-
iture, however, the signalling pathways associated with
the change in sperm metabolism energy are poorly under-
stood. In this study, we observed in sperm that
1,25(OH)2D3, through VDR, reduces triglycerides con-
tent concomitantly to the increase of the lipase activity.
The rate-limiting step in the metabolism of neutral lipids
in adipose tissue lies at the level of the lipase, which cata-
lyzes the hydrolysis of triglyceride [44], high lipase activ-
ity was previously demonstrated in the spermatozoa [45].
However, the endogenous substrate used for energy
metabolism by spermatozoa is species specific and to
what degree triglycerides supply the energy demands of
mammalian spermatozoa is not clear. Particularly, from
our study it appears that 1,25(OH)2D3 doesn't affect FFA
β-oxidation or G6PDH activities and this may be
explained by the fact that the increased lipase activity is
regulated by Ca2+ [46] and therefore, this effect might be
imputable to 1,25(OH)2D3 calcemic action.
Intriguingly, it appears that 1,25(OH)2D3 differently
influences lipid metabolism in adipocytes and in sperm.
In human adipocytes 1,25(OH)2D3 stimulates Ca2+
influx, promotes lipogenesis and inhibits lipolysis via a
rapid nongenomic action [47]. It was demonstrated that
the suppression of 1,25(OH)2D3 by high dietary Ca2+
stimulates lipolysis, inhibits lipogenesis [48] and thereby
shifts the partitioning of dietary energy from energy stor-
age to energy expenditure. Similarly, this 'anti-obesity'
effect of Ca2+ may occur in sperm during capacitation
when Ca2+ influx strongly increases. Therefore, it seems
that, in spite of adipose tissue, 1,25(OH)2D3 has a lipol-
ytic effect in sperm, however an intricate cooperation of
endocrine and autocrine/paracrine factors may exist in
this cell leading to a fine regulation of the energy needed
to the different physiological conditions. The early
increase in sperm intracellular free Ca2+  induced by
1,25(OH)2D3 might be involved in switching the metab-
olism from lipogenesis to lipolysis. Indeed, it may be
speculated that 1,25(OH)2D3 increases the intracellular
Ca2+ mobilization, stimulating the induction of capacita-
tion that requires energy. Therefore the lipid metabolism
increases to meet the energetic demands during the proc-
ess by reducing energy storage and increasing energy
expenditure. Besides, sperm lipid metabolism might be
more sensitive to Ca2+ variations given the importance of
this signalling in sperm. Infact it is important to point out
that intracellular Ca2+ is approximately 50-100 nM in
uncapacitated sperm, 200-1000 nM in hyperactivated
sperm [49] and it may increase to approximately 10 μM
during the acrosome reaction [50].
A wide array of rapid responses stimulated by
1,25(OH)2D3 have been reported [51]. ERK1/2, AKT and
GSK3 have been demonstrated to be involved in different
sperm activities [18,21]. In this study 1,25(OH)2D3 rap-
idly induces all of these pathways indicating that VDR is
involved in various sperm functions and thus corroborat-
ing the unexpected physiological significance of the hor-
mone in the human male gamete.
The hormone concentration can be crucial in determining
the type of cell responsiveness. It was observed in different
cell systems that the hormone level regulates the associa-
tion between different receptors and signalling effectors
suggesting that assembly or disassembly of different mod-
ules are involved in the effects triggered by low and high
hormone concentrations [52,53]. In our study, the
response to 1,25(OH)2D3 appears to be biphasic with a
stimulatory effect at lower concentrations, and becoming
inhibitory or ineffective at the higher levels. The outcome
of signalling activation depending on differences in ligand
level was also recently demonstrated in human sperm
[15,18,21,29,41] and a possible explanation relies in the
down regulation of the receptors at elevated hormone
concentration [54]. The observation that different hor-
mone levels trigger different responses in sperm cells is a
remarkable example of the pronounced flexibility of this
cell in the responsiveness to steroids.
Concluding, sperm local source of 1,25(OH)2D3 may
participate with different actions in the sperm functional
maturation. The data provided by the current experiments
clearly establish a molecular role of the VDR in sperm
physiology and it may be considered as a novel modulator
of sperm fertilizing ability. VDR is present in the seminif-
erous tubules, in spermatogonia [12] and in spermatozoa
[14,15]. In addition to sex steroid hormones, the classic
regulators of reproduction, vitamin D also modulates
reproductive processes in the human female. After sperm
are deposited into the vagina via ejaculation, they must
travel through the cervical mucus into the uterus and then
into the fallopian tube before they can meet with the egg.
The 1 alpha-hydroxylase is expressed in cervical and uter-
ine tissues [55,56]. Vaginal epithelium [57], cervical,
endometrial cells [58] and fallopian epithelial cells
express VDR [59,12] implicating a physiological role of
the 1,25(OH)2D3 in this context. It was reported that the
amount of 1,25(OH)2D3 present in follicular fluid is sig-
nificantly lower than in the concurrent serum [60]. TheseReproductive Biology and Endocrinology 2009, 7:140 http://www.rbej.com/content/7/1/140
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observations may also support our results concerning the
biphasic effect of 1,25(OH)2D3 doses, since lower hor-
mone levels induce the majority of the sperm activities
evaluated, while higher concentrations appear to be inef-
fective. However, the physiological significance and the
specific role of 1,25(OH)2D3/VDR in both gametes need
to be further investigated.
Taken together, our results extended the role of
1,25(OH)2D3 beyond its conventional physiological
actions, enhanced our knowledge on human sperm at
molecular level and our understanding of the vitamin D
signaling pathway, paving the way for novel therapeutic
opportunities in the treatment of the male fertility disor-
ders. The modulation of the VDR might also provide a
mechanism by which environmental or dietary vitamin D




(VDR): 1,25(OH)2D3 receptor; (1α-hydroxylase):
25(OH)D3-1alpha-hydroxylase; (G6PDH): Glucose-6-
phosphate dehydrogenase; (DMSO): Dimethyl Sulfoxide;
(M-MLV): Moloney Murine Leukemia Virus; (ERK 1/2):
Rabbit anti-p-extracellular signal-regulated kinase;
(WHO): World Health Organization; (Dnase): ribonucle-
ase-free deoxyribonuclease; (cDNA): complementary
DNA; (DGGR): 1,2-o-dilauryl-rac-glycero-3-glutaric acid-
(6'-methylresorufin) ester; (Ab): Antibody.
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